Latest news
Loading news…
C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.
C2i Genomics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
C2i Genomics was acquired by Veracyte in 2026.
Total Funding
$112M
Funding Rounds
2
Last Funding
Acquisitions
0
Monthly Visits
Contacts
20
About C2i Genomics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- New York, United States
C2i Genomics Funding Rounds
2 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–2 of 2Show
Page 1 / 1
C2i Genomics Key People
Co-Founder, CEO
Board of Directors
Co-Founder & CTO
Scientific Co-Founder
20
professional contacts at C2i Genomics
Contact execs at C2i Genomics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about C2i Genomics
People who checked this page also checked these
Browse the full Acquirezy directory.